Drawing for AXOGEN

USPTO serial 88041171

AXOGEN

Reviewed by CopyMark Law Group

Reg. 6521140Status 700Renewal
Filing date
Status date
Registration date
Oct 12, 2021
Examiner
MARTIN, CHRISTINE C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AXOGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962United States

Goods and services

ClassDescriptionStatusFirst use
005Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human and animal tissue, for medical and veterinary use; surgical glues; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; medical and veterinary preparations, namely, nerve and tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regenerationACTIVEJul 17, 2007
010Medical, veterinary and diagnostic instruments for use in regenerative medicine, wound repair, surgical repair, and nerve repair and regeneration; nervous tissue products for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration, namely, surgical kits comprised of medical, veterinary and surgical apparatus for use in the field of surgery, namely, medical, veterinary and diagnostic instruments for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration, sutures, dressing, forceps and medical and veterinary instruments for cutting tissue, surgical implants comprised of biological tissue; surgical implants comprised of synthetic materials; sensory testing instruments, namely, aesthesiometers and two-point discriminators; medical and veterinary devices, namely, devices for measuring threshold somatosensory and nerve density in humans and vertebrates; medical devices for measuring human hand's pinch strength; medical and veterinary devices, namely, a nerve function assessment monitor for use in measuring and evaluating sensory and motor function; monitoring system for medical and veterinary use comprised of components measuring pressure sensitivity on the skin, and grip and pinch strength of patients; medical and veterinary instruments and devices, namely, nerve and tissue grafts and implants comprising artificial, non-living materials, for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; implants comprising synthetic materialACTIVEJul 18, 2011
038Providing an online forum for discussion by surgeons on a variety of topics relevant in the surgical community in the medical and veterinary fieldsACTIVEMay 15, 2015
042Scientific research for medical and veterinary purposes in the area of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; scientific research for medical and veterinary purposes in the field of plastic, orthopedic, neurology, urology, and/or ENT surgery; providing medical, veterinary and scientific research information relating to medical and veterinary treatment in the nature of results of scientific research and clinical data in the areas of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and pharmaceutical and veterinary preparations and delivery therefor provided through a database that allows input and collection of data and information; clinical research in the areas of regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and pharmaceutical and veterinary preparations and delivery systems, to provide information on functional recovery and treatment outcomes; research and development of new products and procedures in the pharmaceutical, veterinary and biotechnology fields; development of new technology for others in the fields of pharmaceutical and veterinary preparations and delivery systems therefor, regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, nerve repair and regeneration, and tissue generation, processing and transplantationACTIVEJun 20, 2005

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 13, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 13, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 25, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 25, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 12, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 9, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 8, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 25, 2021RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED—
Feb 25, 2021RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED—
Feb 25, 2021RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED—
Feb 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 13, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 2, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 2, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 2, 2021CNFRSU - FINAL REFUSAL - WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 11, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 11, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2021ALIEASSIGNED TO LIE—
Jan 4, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 4, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 2, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 5, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 15, 2020IUAFUSE AMENDMENT FILED—
May 15, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 28, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 19, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 19, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 11, 2019CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jun 11, 2019APETASSIGNED TO PETITION STAFF—
Jun 11, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 11, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 22, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 15, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 6, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 29, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2019ALIEASSIGNED TO LIE—
Apr 16, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 9, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 2, 2018DOCKASSIGNED TO EXAMINER—
Jul 20, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance